NCT01320176 - Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

HIV

Interventions

BIOLOGICAL

Investigational HIV vaccine dose A

The vaccine will be administered by intramuscular route into the deltoid muscle preferentially of the non dominant arm at Month 0 and Month 3

BIOLOGICAL

Investigational HIV vaccine dose B

The vaccine will be administered by intramuscular route into the deltoid muscle preferentially of the non dominant arm at Month 0 and Month 3

Trial Locations (1)

Gent University & Hospital, Center for Vaccinology, Ghent